Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8572509, 13 pages
https://doi.org/10.1155/2017/8572509
Research Article

Serum Proteome Alterations in Patients with Cognitive Impairment after Traumatic Brain Injury Revealed by iTRAQ-Based Quantitative Proteomics

1Institute of Integrated Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
2Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China

Correspondence should be addressed to Weijun Peng; moc.liamg@7891nujiewgnep, Zhe Wang; moc.621@ehzgnawcire, and Zi-an Xia; nc.ude.usc@naiz.aix

Received 3 October 2016; Revised 1 December 2016; Accepted 13 December 2016; Published 30 January 2017

Academic Editor: Lap Ho

Copyright © 2017 Xin-gui Xiong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Morawska, F. Büchele, C. G. Moreira, L. L. Imbach, D. Noain, and C. R. Baumann, “Sleep modulation alleviates axonal damage and cognitive decline after rodent traumatic brain injury,” Journal of Neuroscience, vol. 36, no. 12, pp. 3422–3429, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Rabinowitz and H. S. Levin, “Cognitive sequelae of traumatic brain injury,” Psychiatric Clinics of North America, vol. 37, no. 1, pp. 1–11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Cristofori and H. S. Levin, “Traumatic brain injury and cognition,” Handbook of Clinical Neurology, vol. 128, pp. 579–611, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. K. R. Walker and G. Tesco, “Molecular mechanisms of cognitive dysfunction following traumatic brain injury,” Frontiers in Aging Neuroscience, vol. 5, article 29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Titus, N. M. Wilson, J. E. Freund et al., “Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor,” Journal of Neuroscience, vol. 36, no. 27, pp. 7095–7108, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Wang, A. Li, Y. Guo et al., “iTRAQ-based proteomics screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors,” Scientific Reports, vol. 6, Article ID 28600, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Li, F. Peng, G. Li et al., “Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis,” Oncotarget, vol. 7, no. 24, pp. 37226–37237, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Muenchhoff, A. Poljak, F. Song et al., “Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts,” Journal of Alzheimer's Disease, vol. 43, no. 4, pp. 1355–1373, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sharma, H. Gowda, S. Chavan et al., “Proteomic signature of endothelial dysfunction identified in the serum of acute ischemic stroke patients by the iTRAQ-based LC-MS approach,” Journal of Proteome Research, vol. 14, no. 6, pp. 2466–2479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Zhang, S. Zhu, Y. Li et al., “Quantitative proteomics analysis to identify diffuse axonal injury biomarkers in rats using iTRAQ coupled LC-MS/MS,” Journal of Proteomics, vol. 133, pp. 93–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Wu, Y. Zhao, S. J. Haidacher et al., “Detection of structural and metabolic changes in traumatically injured hippocampus by quantitative differential proteomics,” Journal of Neurotrauma, vol. 30, no. 9, pp. 775–788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Crawford, G. Crynen, J. Reed et al., “Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model,” Journal of Neurotrauma, vol. 29, no. 2, pp. 246–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Yi, S. Shi, Y. Wang et al., “Serum metabolic profiling reveals altered metabolic pathways in patients with post-traumatic cognitive impairments,” Scientific Reports, vol. 6, article 21320, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Norup, K. S. Kristensen, L. Siert, I. Poulsen, and E. L. Mortensen, “Neuropsychological support to relatives of patients with severe traumatic brain injury in the sub-acute phase,” Neuropsychological Rehabilitation, vol. 21, no. 3, pp. 306–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. W. D. Gouvier, P. D. Blanton, K. K. LaPorte, and C. Nepomuceno, “Reliability and validity of the Disability Rating Scale and the Levels of Cognitive Functioning Scale in monitoring recovery from severe head injury,” Archives of Physical Medicine and Rehabilitation, vol. 68, no. 2, pp. 94–97, 1987. View at Google Scholar · View at Scopus
  16. N. M. A. White, O. Masui, L. V. DeSouza et al., “Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma,” Oncotarget, vol. 5, no. 2, pp. 506–518, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Huang, Q. Liang, J. Chen et al., “Quantitative proteomic analysis of synovial tissue from rats with collagen-induced arthritis,” RSC Advances, vol. 5, no. 105, pp. 86088–86101, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-D. Xu, D.-F. Deng, X. Li et al., “Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS,” Proteomics, vol. 14, no. 2-3, pp. 322–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Wang, L. Wei, L. Shi et al., “Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis,” Scientific Reports, vol. 5, Article ID 15615, 2015. View at Publisher · View at Google Scholar
  20. H. Mi, S. Poudel, A. Muruganujan, J. T. Casagrande, and P. D. Thomas, “PANTHER version 10: expanded protein families and functions, and analysis tools,” Nucleic Acids Research, vol. 44, no. 1, pp. D336–D342, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Szklarczyk, A. Franceschini, S. Wyder et al., “STRING v10: protein-protein interaction networks, integrated over the tree of life,” Nucleic Acids Research, vol. 43, no. 1, pp. D447–D452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Xing, Z. Xia, W. Peng et al., “Xuefu Zhuyu decoction, a traditional Chinese medicine, provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway,” Scientific Reports, vol. 6, Article ID 20040, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. T. M. Sivanandam and M. K. Thakur, “Traumatic brain injury: a risk factor for Alzheimer's disease,” Neuroscience and Biobehavioral Reviews, vol. 36, no. 5, pp. 1376–1381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. B. L. Plassman and J. Grafman, “Traumatic brain injury and late-life dementia,” Handbook of Clinical Neurology, vol. 128, pp. 711–722, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. N. El Kadmiri, I. Slassi, B. El Moutawakil et al., “Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease,” Pathologie Biologie, vol. 62, no. 6, pp. 333–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. Hara and S. H. Snyder, “Nitric oxide-GAPDH-Siah: a novel cell death cascade,” Cellular and Molecular Neurobiology, vol. 26, no. 4–6, pp. 527–538, 2006. View at Google Scholar · View at Scopus
  27. J. Huang, N. Xiong, C. Chen et al., “Glyceraldehyde-3-phosphate dehydrogenase: activity inhibition and protein overexpression in rotenone models for Parkinson's disease,” Neuroscience, vol. 192, pp. 598–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. D. H. O'Day and M. A. Myre, “Calmodulin-binding domains in Alzheimer's disease proteins: extending the calcium hypothesis,” Biochemical and Biophysical Research Communications, vol. 320, no. 4, pp. 1051–1054, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. H. O'Day, K. Eshak, and M. A. Myre, “Calmodulin binding proteins and Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 46, no. 3, pp. 553–569, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yang, T. Zhou, H. Wang et al., “Lipoprotein lipase deficiency leads to α-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction,” Neuroscience, vol. 290, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Xian, T. Liu, J. Yu et al., “Presynaptic defects underlying impaired learning and memory function in lipoprotein Lipase-deficient mice,” The Journal of Neuroscience, vol. 29, no. 14, pp. 4681–4685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Gong, W. Dong, S. W. Rostad et al., “Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus of Alzheimer's disease brains,” Journal of Histochemistry and Cytochemistry, vol. 61, no. 12, pp. 857–868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. K. Kunutsor, H. Khan, K. Nyyssönen, and J. A. Laukkanen, “Is lipoprotein (a) protective of dementia?” European Journal of Epidemiology, vol. 31, no. 11, pp. 1149–1152, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. A. Amar, T. Sakurai, A. Sakurai-Ikuta et al., “A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 352, no. 2, pp. 227–235, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Arias-Vásquez, A. Isaacs, Y. S. Aulchenko et al., “The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease,” Neurogenetics, vol. 8, no. 3, pp. 189–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. J. Yang, S. P. Ma, F. Ju et al., “Thrombospondin-4 promotes neuronal differentiation of NG2 cells via the ERK/MAPK pathway,” Journal of Molecular Neuroscience, vol. 60, no. 4, pp. 517–524, 2016. View at Publisher · View at Google Scholar
  37. E. J. Benner, D. Luciano, R. Jo et al., “Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4,” Nature, vol. 497, no. 7449, pp. 369–373, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Xu, H.-J. Chen, S.-H. Chen et al., “Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer,” Medicine, vol. 95, no. 29, Article ID e4326, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. Y.-F. Xu, X.-Y. Ren, Y.-Q. Li et al., “High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma,” BMC Cancer, vol. 15, no. 1, article 332, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Zhang, X. Yin, H. Yu et al., “Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry,” Analyst, vol. 137, no. 2, pp. 490–495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Zhan, Y.-T. Yang, H.-M. You et al., “Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression,” European Psychiatry, vol. 29, no. 5, pp. 307–315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. Q. Wang, X. Su, X. Jiang et al., “iTRAQ technology-based identification of human peripheral serum proteins associated with depression,” Neuroscience, vol. 330, pp. 291–325, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. P. O. Jenkins, M. A. Mehta, and D. J. Sharp, “Catecholamines and cognition after traumatic brain injury,” Brain, vol. 139, no. 9, pp. 2345–2371, 2016. View at Publisher · View at Google Scholar